Idecabtagene vicleucel (ide-cel) versus standard (std) regimens in patients (pts) with triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): Analysis of cytopenias and infections in pts from KarMMa-3 Meeting Abstract
| Authors: | Baz, R.; Otero, P. R.; Ailawadhi, S.; Arnulf, B.; Patel, K. K.; Nooka, A. K.; Costa, L.; Raje, N. S.; Abrahamsen, I. W.; Delforge, M.; Gergis, U.; Sborov, D. W.; Giralt, S. A.; Raab, M. S.; Ishida, T.; Varshavsky-Yanovsky, A.; Choi, T.; Anderson, L. D. Jr; Truppel-Hartmann, A.; Bhatnagar, R.; Wu, F.; Piasecki, J.; Felten, J.; Caia, A.; Cook, M.; Lin, Y. |
| Abstract Title: | Idecabtagene vicleucel (ide-cel) versus standard (std) regimens in patients (pts) with triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): Analysis of cytopenias and infections in pts from KarMMa-3 |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 4879 |
| Language: | English |
| ACCESSION: | WOS:001159900800080 |
| DOI: | 10.1182/blood-2023-174477 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
